177 related articles for article (PubMed ID: 33531581)
1. Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma.
Moore MR; Friesner ID; Rizk EM; Fullerton BT; Mondal M; Trager MH; Mendelson K; Chikeka I; Kurc T; Gupta R; Rohr BR; Robinson EJ; Acs B; Chang R; Kluger H; Taback B; Geskin LJ; Horst B; Gardner K; Niedt G; Celebi JT; Gartrell-Corrado RD; Messina J; Ferringer T; Rimm DL; Saltz J; Wang J; Vanguri R; Saenger YM
Sci Rep; 2021 Feb; 11(1):2809. PubMed ID: 33531581
[TBL] [Abstract][Full Text] [Related]
2. Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma.
Chou M; Illa-Bochaca I; Minxi B; Darvishian F; Johannet P; Moran U; Shapiro RL; Berman RS; Osman I; Jour G; Zhong H
Mod Pathol; 2021 Mar; 34(3):562-571. PubMed ID: 33005020
[TBL] [Abstract][Full Text] [Related]
3. An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma.
Acs B; Ahmed FS; Gupta S; Wong PF; Gartrell RD; Sarin Pradhan J; Rizk EM; Gould Rothberg B; Saenger YM; Rimm DL
Nat Commun; 2019 Nov; 10(1):5440. PubMed ID: 31784511
[TBL] [Abstract][Full Text] [Related]
4. A Novel Numerical Scoring System for Melanoma Tumor-infiltrating Lymphocytes Has Better Prognostic Value Than Standard Scoring.
Saldanha G; Flatman K; Teo KW; Bamford M
Am J Surg Pathol; 2017 Jul; 41(7):906-914. PubMed ID: 28368925
[TBL] [Abstract][Full Text] [Related]
5. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Melanoma Using Pathologic Features Identified by Natural Language Processing.
Yang J; Lian JW; Chin YH; Wang L; Lian A; Murphy GF; Zhou L
JAMA Netw Open; 2021 Sep; 4(9):e2126337. PubMed ID: 34550383
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.
Thomas NE; Busam KJ; From L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Groben PA; Hao H; Orlow I; Reiner AS; Luo L; Paine S; Ollila DW; Wilcox H; Begg CB; Berwick M
J Clin Oncol; 2013 Nov; 31(33):4252-9. PubMed ID: 24127443
[TBL] [Abstract][Full Text] [Related]
8. Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms.
Aung TN; Shafi S; Wilmott JS; Nourmohammadi S; Vathiotis I; Gavrielatou N; Fernandez A; Yaghoobi V; Sinnberg T; Amaral T; Ikenberg K; Khosrotehrani K; Osman I; Acs B; Bai Y; Martinez-Morilla S; Moutafi M; Thompson JF; Scolyer RA; Rimm DL
EBioMedicine; 2022 Aug; 82():104143. PubMed ID: 35810563
[TBL] [Abstract][Full Text] [Related]
9. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
10. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
[TBL] [Abstract][Full Text] [Related]
11. Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.
Gartrell RD; Marks DK; Rizk EM; Bogardus M; Gérard CL; Barker LW; Fu Y; Esancy CL; Li G; Ji J; Rui S; Ernstoff MS; Taback B; Pabla S; Chang R; Lee SJ; Krolewski JJ; Morrison C; Horst BA; Saenger YM
Clin Cancer Res; 2019 Apr; 25(8):2494-2502. PubMed ID: 30647081
[TBL] [Abstract][Full Text] [Related]
12. Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases.
Chatziioannou E; Roßner J; Aung TN; Rimm DL; Niessner H; Keim U; Serna-Higuita LM; Bonzheim I; Kuhn Cuellar L; Westphal D; Steininger J; Meier F; Pop OT; Forchhammer S; Flatz L; Eigentler T; Garbe C; Röcken M; Amaral T; Sinnberg T
EBioMedicine; 2023 Jul; 93():104644. PubMed ID: 37295047
[TBL] [Abstract][Full Text] [Related]
13. Local immune response predicts survival in patients with thick (t4) melanomas.
Cintolo JA; Gimotty P; Blair A; Guerry D; Elder DE; Hammond R; Elenitsas R; Xu X; Fraker D; Schuchter LM; Czerniecki BJ; Karakousis G
Ann Surg Oncol; 2013 Oct; 20(11):3610-7. PubMed ID: 23838911
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
15. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
16. Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death.
Kulkarni PM; Robinson EJ; Sarin Pradhan J; Gartrell-Corrado RD; Rohr BR; Trager MH; Geskin LJ; Kluger HM; Wong PF; Acs B; Rizk EM; Yang C; Mondal M; Moore MR; Osman I; Phelps R; Horst BA; Chen ZS; Ferringer T; Rimm DL; Wang J; Saenger YM
Clin Cancer Res; 2020 Mar; 26(5):1126-1134. PubMed ID: 31636101
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
18. Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma.
Johannet P; Coudray N; Donnelly DM; Jour G; Illa-Bochaca I; Xia Y; Johnson DB; Wheless L; Patrinely JR; Nomikou S; Rimm DL; Pavlick AC; Weber JS; Zhong J; Tsirigos A; Osman I
Clin Cancer Res; 2021 Jan; 27(1):131-140. PubMed ID: 33208341
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 expression in tumour-infiltrating lymphocytes is a poor prognostic factor for primary acral melanoma patients.
Ren M; Dai B; Kong YY; Lv JJ; Cai X
Histopathology; 2018 Sep; 73(3):386-396. PubMed ID: 29637587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
